Skip to main content

CannabisNewsBreaks – WEED Inc.’s (BUDZ) HEMP BioSciences Inc. Receives Full Suite of Industrial Hemp Licenses from State of Arizona

WEED (OTCQB: BUDZ) is a global cannabis and hemp bioresearch company based in the U.S. focused on the development and application of cannabis–derived compounds for the treatment of human and animal diseases. The company, together with its HEMP BioSciences Inc. (“HEMP”) division, today announced its intention to expand into consumer packaged goods utilizing its rare Landrace strains including Original Panama Red, Acapulco Gold, Red Bud Colombian and Santa Marta Gold.

“HEMP has been issued all required licenses for Industrial HEMP; Growing, Nursery, Harvester, Transporter and Processor licenses under Title 3-Chapter 2-Article 4.1 of The Arizona Department of Agriculture,” said Nicole Marie Breen, COO of HEMP BioSciences. “With the renewal of our hemp licenses, we are now in the process of acquiring a cGMP certification to ensure the highest quality products, while protecting the public in this highly regulated industry. We believe HEMP’s CBD gummies, oils, cremes, tinctures, balms, both broad and full spectrum, will maximize the entourage effects under the strictest manufacturing processes globally.”

To view the full press release, visit https://cnw.fm/0D1k1

About WEED Inc.

WEED is a leading cannabis company dedicated to delivering exceptional products and experiences to the cannabis consumer market. With operations spanning Israel, Australia and the USA, the company focuses on innovation, quality and sustainability. Through strategic acquisitions and partnerships, WEED aims to shape the future of the cannabis industry.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.